Design concepts and principle of operation of the HeartWare ventricular assist system.

Implantable left ventricular assist devices provide circulatory support for patients at risk of death from refractory, end-stage heart failure. Rotary blood pumps have been designed for increased reliability and smaller size for use in a broader population of patients than the first-generation pulsatile devices. The design concepts and principle of operation of the HeartWare System are discussed. The HeartWare Ventricular Assist System (HVAD) is a small centrifugal flow pump with a displacement volume of 50 ml and an output capacity of 10 L/min. A unique wide-blade impeller is suspended by hybrid passive magnets and hydrodynamic forces. An integrated inflow cannula is inserted into the left ventricle and is held in position by an adjustable sewing ring; the pump is positioned in the pericardial space. The 10-mm outflow graft is anastomosed to the ascending aorta. External system components include the microprocessor-based controller, a monitor, lithium-ion battery packs, alternating current and direct current power adapters, and a battery charger. Physiologic control algorithms are incorporated for safe operation. Preclinical life cycle tests have shown the HVAD to be highly reliable. This system design offers reliability, portability, and ease of use for ambulatory patients.

[1]  James W Long,et al.  Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. , 2005, Congestive heart failure.

[2]  R. Schwartzman,et al.  Neurologic complications of the Novacor left ventricular assist device. , 2001, The Annals of thoracic surgery.

[3]  W. Holman Microbiology of Infection in Mechanical Circulatory Support , 2007, The International journal of artificial organs.

[4]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[5]  Nader Moazami,et al.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.

[6]  T. Myers,et al.  Infectious complications associated with ventricular assist systems. , 2000, ASAIO journal.

[7]  S. Furukawa,et al.  Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation , 2005, Transplant infectious disease : an official journal of the Transplantation Society.

[8]  M. Oz,et al.  Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  Thierry G Mesana,et al.  Rotary blood pumps for cardiac assistance: a "must"? , 2004, Artificial organs.

[10]  G. Beilman,et al.  Abdominal complications of ventricular assist device placement. , 2005, Surgical infections.

[11]  B. Hota,et al.  Left ventricular assist device-related infection: treatment and outcome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  P M Portner,et al.  Improved outcomes with an implantable left ventricular assist system: a multicenter study. , 2001, The Annals of thoracic surgery.

[13]  G. Couper,et al.  Infection in permanent circulatory support: experience from the REMATCH trial. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  V. Jeevanandam,et al.  Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. , 1996, Circulation.